| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.06 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.06 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.06 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.06 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |